Market Overview:
The global human CYP2C19 gene detection kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for genetic screening, reproductive genetic testing, and diagnostic tests. Additionally, the increasing prevalence of diseases such as cancer and heart disease is also contributing to the growth of this market. Based on type, the global human CYP2C19 gene detection kit market can be segmented into genetic screening, reproductive genetic testing, diagnostic test, and gene carrier test. Genetic screening is expected to account for a major share of this market in 2018 owing to its growing demand for prenatal diagnosis and newborn screening programs across the world. Reproductive genetic testing is also anticipated to witness significant growth during the forecast period due its rising use in pre-implantation diagnosis (PGD) and pre-natal diagnosis (PND).
Product Definition:
The Human CYP2C19 Gene Detection Kit is a molecular biology assay designed to detect the presence of human CYP2C19 gene sequences in a sample. The kit can be used as a research tool to help elucidate the role of this gene in human physiology and pharmacology, or as a quality control measure for laboratories that sequence DNA from human samples.
Genetic Screening:
A genetic test is a procedure to find out whether an individual has a mutation in the CYP2C19 gene. This can be done by testing of DNA from the blood sample. The presence or absence of this particular gene provides information about the risk for developing certain diseases such as pancreatic cancer, acute pancreatitis, and other related diseases.
The growing prevalence of these disorders coupled with increasing demand for early diagnosis are factors expected to drive growth during the forecast period.
Reproductive Genetic Testing:
A. The global reproductive genetic testing (RGT) market size was valued at USD 1,B2 million in 2015 and is expected to grow at a CAGR of XX% during the forecast period. The growing demand for advanced fertility treatments coupled with increasing prevalence of infertility is anticipated to drive the growth of this industry in near future.
Application Insights:
Based on application, the global human CYP2C19 gene detection kit market is segmented into hospital, clinic and diagnostic center. The hospital segment dominated the overall market in terms of revenue in 2017 owing to an increase in number of patients suffering from drug-resistant epilepsy with a high unmet medical need. Moreover, increasing prevalence of chronic diseases such as cancer and cardiovascular disorders also boosts demand for rapid diagnosis which is further anticipated to propel growth over the forecast period.
The growing importance of genetic testing for disease susceptibility has led clinicians to recommend this procedure to their patients who are at risk of developing rarer forms of cancer or other metabolic disorders caused by mutations in tumor suppressor genes such as CYP2C19. In addition, there is an increased focus on early diagnosis through carrier screening due to a relatively higher risk associated with it compared with sporadic cases among healthy individuals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, availability of advanced technologies and high adoption rate for novel diagnostic techniques. Moreover, increasing prevalence of genetic disorders is also expected to drive regional growth over the forecast period. For instance, according to statistics published by National Human Genome Research Institute (NHLBI), in United States around 30 million people are living with cystic fibrosis which is associated with an increased risk for lung cancer.
Asia Pacific region is anticipated to witness lucrative growth over the coming years owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of clinical trials for new drug development
- Rising prevalence of chronic diseases
- Technological advancements in gene detection kits
- Growing awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Human CYP2C19 Gene Detection Kit Market Research Report
By Type
Genetic Screening, Reproductive Genetic Testing, Diagnostic Test, Gene carrier Test
By Application
Hospital, Clinic, Diagnostic Center
By Companies
Sinochips, Easydiagnosis, KingMed, Helixgen, EZlifeBio, Sansure
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Human CYP2C19 Gene Detection Kit Market Report Segments:
The global Human CYP2C19 Gene Detection Kit market is segmented on the basis of:
Types
Genetic Screening, Reproductive Genetic Testing, Diagnostic Test, Gene carrier Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sinochips
- Easydiagnosis
- KingMed
- Helixgen
- EZlifeBio
- Sansure
Highlights of The Human CYP2C19 Gene Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Genetic Screening
- Reproductive Genetic Testing
- Diagnostic Test
- Gene carrier Test
- By Application:
- Hospital
- Clinic
- Diagnostic Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human CYP2C19 Gene Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Human CYP2C19 Gene Detection Kit is a genetic test that can be used to determine the presence of the CYP2C19 gene. This test is typically used to diagnose conditions related to the metabolism of drugs, including drug abuse and addiction.
Some of the major players in the human cyp2c19 gene detection kit market are Sinochips, Easydiagnosis, KingMed, Helixgen, EZlifeBio, Sansure.
The human cyp2c19 gene detection kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human CYP2C19 Gene Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human CYP2C19 Gene Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human CYP2C19 Gene Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human CYP2C19 Gene Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human CYP2C19 Gene Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Human CYP2C19 Gene Detection Kit Market Size and Y-o-Y Growth
4.5.2 Human CYP2C19 Gene Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Genetic Screening
5.2.2 Reproductive Genetic Testing
5.2.3 Diagnostic Test
5.2.4 Gene carrier Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human CYP2C19 Gene Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human CYP2C19 Gene Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Genetic Screening
9.6.2 Reproductive Genetic Testing
9.6.3 Diagnostic Test
9.6.4 Gene carrier Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Genetic Screening
10.6.2 Reproductive Genetic Testing
10.6.3 Diagnostic Test
10.6.4 Gene carrier Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Genetic Screening
11.6.2 Reproductive Genetic Testing
11.6.3 Diagnostic Test
11.6.4 Gene carrier Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Genetic Screening
12.6.2 Reproductive Genetic Testing
12.6.3 Diagnostic Test
12.6.4 Gene carrier Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Genetic Screening
13.6.2 Reproductive Genetic Testing
13.6.3 Diagnostic Test
13.6.4 Gene carrier Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human CYP2C19 Gene Detection Kit Market: Competitive Dashboard
14.2 Global Human CYP2C19 Gene Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sinochips
14.3.2 Easydiagnosis
14.3.3 KingMed
14.3.4 Helixgen
14.3.5 EZlifeBio
14.3.6 Sansure
